Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Pathways for Preterm Birth: The PEPP Study

NCT05246579 is registered in ClinicalTrials.gov with John O'Brien, MD as lead sponsor.

NCT NCT05246579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05246579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Pathways for Preterm Birth: The PEPP Study
Lead sponsor
John O'Brien, MD
Phase
Observational
Overall status
Recruiting
Start date
February 4, 2022
Completion date
July 1, 2027
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervix; pregnancy, preterm birth